NCT00043368 2009-03-12PF-3512676 (CPG 7909) Injection For Patients Who Completed An Oncology Study Using PF-3512676 (CPG 7909)PfizerPhase 2 Completed31 enrolled
NCT00043420 2009-02-12CPG 7909 in Patients With Cutaneous T-Cell LymphomaPfizerPhase 1/2 Completed42 enrolled